Kevin Capps

Kevin Capps is an associate in the Intellectual Property Practice Group in the firm's Del Mar Heights office.

Areas of Practice

Dr. Capps is a registered patent attorney. His practice focuses on patent prosecution, opinions, counseling, and licensing for the pharmaceutical, life science, and chemical industries.  He has represented clients in a range of technological fields, including pharmaceutical small molecules, formulations, and methods, biotechnology, medical devices, and polymers.

Before law school, Dr. Capps was a Patent Examiner at the United States Patent and Trademark Office, where he examined applications directed to therapeutic methods, pharmaceutical compounds and formulations, and cosmetic compositions.  He also previously conducted graduate research on the development of new therapeutics employing both combinatorial chemistry and traditional medicinal chemistry strategies, and undergraduate research on the synthesis of carbohydrates and glycopeptides.

Education

• J.D., University of San Diego, 2010
• Ph.D., Chemistry, The Scripps Research Institute, 2005
• B.S., Biochemistry, University of Maryland – College Park, 2000

Admissions

• California
• U.S. Patent and Trademark Office

Articles

• K. J. Capps, J. Humiston, I. Hwang, D. L. Boger, “AICAR Tfase Inhibitors that Disrupt Requisite Enzyme Dimerization” Bioorg. Med. Chem. Lett. 15: 2840-2844 (2005)
• D. L. Boger, J. Desharnais, K. Capps, “Solution-Phase Combinatorial Libraries: Modulating Cellular Signaling by Targeting Protein-Protein or Protein-DNA Interactions” Angew. Chem. Int. Ed. Engl. 42: 4138-4176 (2003)
• T. H. Marsilije, M. P. Hedrick, J. Desharnais, K. Capps, A. Tavassoli, Y. Zhang, I. A. Wilson, S. J. Benkovic, D. L. Boger, “10-(2-benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid: A Potential Inhibitor of GAR Transformylase and AICAR Transformylase” Bioorg. Med. Chem. 11: 4503-4509 (2003)
• J. Goldberg, Q. Jin, Y. Ambroise, S. Satoh, J. Desharnais, K. Capps, D. L. Boger, “Erythropoietin Mimetics Derived from Solution Phase Combinatorial Libraries” J. Am. Chem. Soc. 124: 544-555 (2002)

Life Sciences Law Blog Articles

• "Supreme Court Holds That a Law of Nature Applied Using Known and Obvious Steps Is Not Patent Eligible," March 28, 2012

Speeches

• “Recent Trends in Federal Circuit Case Law on the Non-obviousness of Pharmaceutical Compounds and Formulations,” American Chemical Society National Meeting, San Diego, CA, March 25, 2012
• "Understanding the Perspective of Examiners in Order to Facilitate the Patent Application Process," American Chemical Society National Meeting, Anaheim, CA, March 28, 2011
• “Practical Tips on Patent Prosecution from the Perspective of a Former Examiner,” American Chemical Society National Meeting, Philadelphia, PA, August 21, 2008